|
NIPSNAP3B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.544300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.182000E-01 |
| Normal-vs-Stage2 |
7.020600E-01 |
| Normal-vs-Stage3 |
1.431370E-04 |
| Normal-vs-Stage4 |
4.765900E-04 |
| Stage1-vs-Stage2 |
7.298400E-01 |
| Stage1-vs-Stage3 |
3.42019999999277E-06 |
| Stage1-vs-Stage4 |
1.043020E-04 |
| Stage2-vs-Stage3 |
8.676400E-02 |
| Stage2-vs-Stage4 |
5.792000E-02 |
| Stage3-vs-Stage4 |
5.820600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.125690E-02 |
| Normal-vs-AfricanAmerican |
3.909800E-01 |
| Normal-vs-Asian |
3.712600E-01 |
| Caucasian-vs-AfricanAmerican |
5.082200E-03 |
| Caucasian-vs-Asian |
2.372200E-01 |
| AfricanAmerican-vs-Asian |
4.761600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.372200E-02 |
| Normal-vs-Female |
1.169190E-01 |
| Male-vs-Female |
8.037600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.996500E-02 |
| Normal-vs-Age(41-60Yrs) |
5.742000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.297700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.120210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.717500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.683000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.204800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.656400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.473200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.745400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.675580E-01 |
| Normal-vs-Grade 2 |
6.946000E-01 |
| Normal-vs-Grade 3 |
7.827900E-04 |
| Normal-vs-Grade 4 |
5.94489999999892E-05 |
| Grade 1-vs-Grade 2 |
2.477000E-01 |
| Grade 1-vs-Grade 3 |
1.582960E-03 |
| Grade 1-vs-Grade 4 |
2.863000E-03 |
| Grade 2-vs-Grade 3 |
5.55249999999452E-05 |
| Grade 2-vs-Grade 4 |
1.86980999999919E-05 |
| Grade 3-vs-Grade 4 |
3.141600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.263400E-01 |
| Normal-vs-ccB subtype |
1.382150E-03 |
| ccA subtype-vs-ccB subtype |
1.810520E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.045900E-02 |
| Normal-vs-N1 |
4.037400E-04 |
| N0-vs-N1 |
8.192200E-02 |
|
|
